Information Provided By:
Fly News Breaks for April 21, 2016
SYK
Apr 21, 2016 | 07:25 EDT
Canaccord raised its price target on Stryker to $122 from $113 after the company's quarterly report, citing its solid revenue growth in U.S. orthopedics, raised guidance, and the potential for operating and tax leverage beyond guidance. Canaccord reiterated its Buy rating on Stryker shares.